Safety evaluation of one whole-cell and three acellular pertussis vaccines in Stockholm trial II
Heijbel, H.; Rasmussen, F.; Olin, P.
Developments in Biological Standardization 89: 99-100
1997
ISSN/ISBN: 0301-5149 PMID: 9272337 Document Number: 479160
Document emailed within 1 workday
Related Documents
Corbel, M. J. 1993: Developments in Biological Standardization, volume 73. Pertussis: Evaluation and Research on Acellular Pertussis Vaccines Journal of Medical Microbiology 38(2): 155-156Blumberg, D.A.; Pineda, E.; Cherry, J.D.; Caruso, A.; Scott, J.V. 1992: The agglutinin response to whole-cell and acellular pertussis vaccines is Bordetella pertussis--strain dependent American Journal of Diseases of Children 146(10): 1148-1150
Rennels, M.B.; Reed, G.F.; Decker, M.D.; Edwards, K.M.; Pichichero, M.E.; Deloria, M.A.; Englund, J.A.; Anderson, E.L.; Steinhoff, M.C.; Deforest, A. 1995: Simultaneous administration of Haemophilus influenzae type b vaccine with acellular or whole-cell pertussis vaccine: effects on reactogenicity and immune responses to pertussis vaccines Pediatrics 96(3 Pt 2): 576-579
Kallings, L.O.; Olin, P.; Storsaeter, J. 1988: Protective effect of 2 acellular pertussis vaccines in a double-blind placebo controlled clinical trial Lakartidningen 85(22): 1994-1996
Giuliano, M.; Mastrantonio, P.; Giammanco, A.; Bottone, M.; Piscitelli, A.; Di Tommaso, S.; Robino, L.; Basso, F.; D'Orazio, P. 1997: Antibody kinetics and long-term sero-prevalence in the Italian clinical trial of acellular pertussis vaccines Developments in Biological Standardization 89: 275-278
Noble, G.R.; Bernier, R.H.; Esber, E.C.; Hardegree, M.C.; Hinman, A.R.; Klein, D.; Saah, A.J. 1987: Acellular and whole-cell pertussis vaccines in Japan. Report of a visit by US scientists JAMA 257(10): 1351-1356
Christy, C.; Pichichero, M.E.; Reed, G.F.; Decker, M.D.; Anderson, E.L.; Rennels, M.B.; Englund, J.A.; Edwards, K.M.; Steinhoff, M.C. 1995: Effect of gender, race, and parental education on immunogenicity and reported reactogenicity of acellular and whole-cell pertussis vaccines Pediatrics 96(3 Pt 2): 584-587
Corbel, M.J.; Xing, D.K. 1997: A consideration of control requirements for acellular pertussis vaccines Developments in Biological Standardization 89: 343-347
Schmitt-Grohé, S.; Stehr, K.; Cherry, J.D.; Heininger, U.; Uberall, M.A.; Laussucq, S.; Eckhardt, T. 1997: Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group Developments in Biological Standardization 89: 113-118
Trollfors, B. 1997: Factors influencing antibody responses to acellular pertussis vaccines Developments in Biological Standardization 89: 279-282
Storsaeter, J.; Gustafsson, L. 1997: Absolute efficacy of acellular pertussis vaccines in household settings Developments in Biological Standardization 89: 153-159
Rappuoli, R. 1996: Acellular pertussis vaccines: a turning point in infant and adolescent vaccination Infectious Agents and Disease 5(1): 21-28
Hewlett, E.L. 1996: Acellular pertussis trial Pediatrics 98(4 Pt 1): 800
Shek, L.Pei.Chi.; Khor, E.Sek.Hoon.; Tan, G.Huat.; Low, K.Tzay.; Ong, D.; Roy, J.; Han, H.Htay.; Bock, H.Ludwig.; Lee, B.Wah. 2003: Comparative study of the reactogenicity of a three-component acellular pertussis vaccine and whole-cell pertussis vaccine administered to healthy Singaporean infants Southeast Asian Journal of Tropical Medicine and Public Health 34(4): 863-868
Granoff, D.M.; Rappuoli, R. 1997: Are serological responses to acellular pertussis antigens sufficient criteria to ensure that new combination vaccines are effective for prevention of disease? Developments in Biological Standardization 89: 379-389
Isomura, S. 1991: Clinical studies on efficacy and safety of an acellular pertussis vaccine in Aichi Prefecture, Japan Developments in Biological Standardization 73: 37-42
Bose, A.; Dubey, A.P.; Gandhi, D.; Pandit, A.; Raghu, M.B.; Raghupathy, P.; Rao, M.I.S.; Verghese, V.P.; Datta, S.K.; Bock, H.L. 2007: Safety and reactogenicity of a low dose diphtheria tetanus acellular pertussis vaccine (Boostrix) in pre-school Indian children Indian Pediatrics 44(6): 421-424
Deloria, M.A.; Blackwelder, W.C.; Decker, M.D.; Englund, J.A.; Steinhoff, M.C.; Pichichero, M.E.; Rennels, M.B.; Anderson, E.L.; Edwards, K.M. 1995: Association of reactions after consecutive acellular or whole-cell pertussis vaccine immunizations Pediatrics 96(3 Pt 2): 592-594
Isomura, S.; Suzuki, S.; Sato, Y. 1985: Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patients Developments in Biological Standardization 61: 531-537
Cheng, H.Kock.; Rajadurai, V.S.; Amin, Z.; Sriram, B.; Yee, M.F.; Han, H.H.; Bock, H.L.; Safary, A. 2004: Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine Southeast Asian Journal of Tropical Medicine and Public Health 35(3): 685-692